These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38204260)

  • 1. Design and Synthesis of Aspirin-chalcone Mimic Conjugates as Potential Anticancer Agents.
    Mohamed-Ezzat RA; Srour AM
    Anticancer Agents Med Chem; 2024; 24(7):544-557. PubMed ID: 38204260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of novel imidazole-chalcone derivatives as microtubule protein polymerization inhibitors to treat cervical cancer and reverse cisplatin resistance.
    Liu Z; Yang Z; Ablise M
    Bioorg Chem; 2024 Jun; 147():107310. PubMed ID: 38583249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of benzo[d]imidazo[2,1-b]thiazole-chalcone conjugates as microtubule targeting and apoptosis inducing agents.
    Sultana F; Reddy Bonam S; Reddy VG; Nayak VL; Akunuri R; Rani Routhu S; Alarifi A; Halmuthur MSK; Kamal A
    Bioorg Chem; 2018 Feb; 76():1-12. PubMed ID: 29102724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 2-[thio]acetamide linked quinazoline/1,2,4-triazole/chalcone hybrids: Design, synthesis, and anticancer activity as EGFR inhibitors and apoptotic inducers.
    Abdelkhalek AS; Kothayer H; Soltan MK; Ibrahim SM; Elbaramawi SS
    Arch Pharm (Weinheim); 2024 Jul; 357(7):e2300627. PubMed ID: 38593298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of novel imidazole-chalcone derivatives as potential anticancer agents and tubulin polymerization inhibitors.
    Rahimzadeh Oskuei S; Mirzaei S; Reza Jafari-Nik M; Hadizadeh F; Eisvand F; Mosaffa F; Ghodsi R
    Bioorg Chem; 2021 Jul; 112():104904. PubMed ID: 33933802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of novel bischalcone derivatives as potential anticancer agents.
    Burmaoglu S; Gobek A; Aydin BO; Yurtoglu E; Aydin BN; Ozkat GY; Hepokur C; Ozek NS; Aysin F; Altundas R; Algul O
    Bioorg Chem; 2021 Jun; 111():104882. PubMed ID: 33839582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of different heterocycles-linked chalcone conjugates as cytotoxic agents and tubulin polymerization inhibitors.
    Shankaraiah N; Nekkanti S; Brahma UR; Praveen Kumar N; Deshpande N; Prasanna D; Senwar KR; Jaya Lakshmi U
    Bioorg Med Chem; 2017 Sep; 25(17):4805-4816. PubMed ID: 28774575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel HDAC/Tubulin Dual Inhibitor: Design, Synthesis and Docking Studies of α-Phthalimido-Chalcone Hybrids as Potential Anticancer Agents with Apoptosis-Inducing Activity.
    Mourad AAE; Mourad MAE; Jones PG
    Drug Des Devel Ther; 2020; 14():3111-3130. PubMed ID: 32848361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, biological evaluation and molecular docking studies of new chalcone derivatives containing diaryl ether moiety as potential anticancer agents and tubulin polymerization inhibitors.
    Wang G; Liu W; Gong Z; Huang Y; Li Y; Peng Z
    Bioorg Chem; 2020 Jan; 95():103565. PubMed ID: 31927336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of thiazole-based-chalcones and 4-hetarylthiazoles as potent anticancer agents: Synthesis, docking study and anticancer activity.
    Farghaly TA; Masaret GS; Muhammad ZA; Harras MF
    Bioorg Chem; 2020 May; 98():103761. PubMed ID: 32200332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational Design and Synthesis of Isatin-Chalcone Hybrids Integrated with 1H-1,2,3-Triazole: Anti-Proliferative Profiling and Molecular Docking Insights.
    Swati ; Raza A; Chowdhary S; Anand A; Shaveta ; Sharma AK; Kumar K; Kumar V
    ChemMedChem; 2024 Jul; 19(14):e202400015. PubMed ID: 38638026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis and Bioactivity Evaluation of Novel Chalcone Derivatives Possessing Tryptophan Moiety with Dual Activities of Anti-Cancer and Partially Restoring the Proliferation of Normal Kidney Cells Pre-Treated with Cisplatin.
    He M; Yu M; Li C; Meng X; Su J; Zhu Y; Yao R
    Anticancer Agents Med Chem; 2022; 22(10):1945-1961. PubMed ID: 34674626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of pyridine-chalcone derivatives as novel microtubule-destabilizing agents.
    Xu F; Li W; Shuai W; Yang L; Bi Y; Ma C; Yao H; Xu S; Zhu Z; Xu J
    Eur J Med Chem; 2019 Jul; 173():1-14. PubMed ID: 30981112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, and
    Alimujiang Y; Maimaiti A; Ablise M; Yang Z; Liu Z; Wang Y; Mutalipu Z; Yan T
    Anticancer Agents Med Chem; 2024; 24(6):423-435. PubMed ID: 38204258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of chalcone acetamide derivatives against triple negative breast cancer.
    Kumar P; Singh R; Sharma D; Hassan QP; Gopu B; Anal JMH
    Bioorg Med Chem Lett; 2024 Jul; 107():129795. PubMed ID: 38750906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
    Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
    Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
    Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
    Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
    Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
    Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of imidazo[2,1-b]thiazole-chalcone conjugates: microtubule-destabilizing agents.
    Kamal A; Balakrishna M; Nayak VL; Shaik TB; Faazil S; Nimbarte VD
    ChemMedChem; 2014 Dec; 9(12):2766-80. PubMed ID: 25313981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Pyrazole-Chalcone Hybrids: Synthesis and Computational Insights Against Breast Cancer.
    Dabhade PS; Dabhade MP; Rathod LS; Dhawale SA; More SA; Chaudhari SY; Mokale SN
    Chem Biodivers; 2024 Jul; 21(7):e202400015. PubMed ID: 38705852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.